Deadline: applications must be submitted by 9 November 2026. The Interconnect Innovation Catalyst Program 2026 strengthens India's biomedical innovation ecosystem by enabling collaboration and structured support. Implemented by Bharathiya Vikas Trust (BVT) and supported by Blockchain for Impact (BFI), this one-year programme helps innovators scale, validate, and build viable pathways to impact.
Cohort 2 is open for biomedical innovators at Technology Readiness Level (TRL) 4+. Up to 50 fellows will receive funding of up to ₹30,00,000 over 12 months, disbursed quarterly based on milestone achievements, along with mentorship and market access.
Eligibility
Applicants must be biomedical innovators working at TRL 4 and above — meaning the technology has been validated in a lab environment and is ready for development toward real-world application. The programme is designed for innovators who can demonstrate a clear pathway to impact in the biomedical domain.
How to apply for the Interconnect Innovation Catalyst
Applications close on 9 November 2026. Innovators should prepare documentation of their technology's TRL, validation evidence, and a milestone-based plan for the 12-month programme, since funding is disbursed quarterly against milestones. Apply through the programme's official application channel; selected fellows also gain mentorship and market access alongside the funding.
Why it matters for founders
Milestone-based grants are the best non-dilutive capital for biotech and medtech founders: ₹30 lakh over a year, tied to progress, not equity. If your lab innovation is past proof-of-concept (TRL 4+), the Interconnect Innovation Catalyst gives you runway plus mentorship. The November 9 deadline is close — start the application now.